Mycophenolate Mofetil for Injection
Mylan recalls Mycophenolate Mofetil for Injection 500 mg/vial due to precipitate.
Consumers who have the affected product should stop using it immediately and contact their healthcare provider or pharmacist for guidance. Return the product to the place of purchase or contact Mylan Pharmaceuticals for further instructions.
Recall at a glance
- Quantity recalled
- 5688 vials
Why it was recalled
Mylan Pharmaceuticals is recalling Mycophenolate Mofetil for Injection USP, 500 mg/vial single-dose vials, due to the presence of precipitate. The affected product is used as an immunosuppressant and was distributed in the U.S.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Mycophenolate Mofetil for Injection USP
- Lot code
- 3241653, 2027
- Strength
- 500 mg
- NDC / UPC
- NDC 67457-386-00, NDC 67457-386-81
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Product Quality Defect recalls
Other recent recalls from MYLAN PHARMACEUTICALS INC
Editorial summary by Recall Canary · summary updated 2026-08-13 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification